Back to Search
Start Over
BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
- Source :
- Plus Company Updates. January 29, 2018
- Publication Year :
- 2018
-
Abstract
- NEW YORK : BeyondSpring Inc has issued the following press release: BeyondSpring Inc. (NASDAQ:BYSI), a global clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced that [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.525409445